Research Options: Select below IPO Calendar	Week of Expected Pricing Withdrawn Company Name Virobay Inc Proposed Ticker VBAY CUSIP 92823J100 Business Description A clinical-stage biopharmaceutical company utilizing our cysteine cathepsin platform for the development and commercialization of novel drugs. Lead Underwriter JMP Securities LLC, Piper Jaffray & Co. Co-Managers Cantor Fitzgerald and Co, Summer Street Research Partners. Initial Shares 3,846,153 Revised Initial Shares N/A Initial Price $12.00-$14.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.